TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 1639946

Group type: EXPERIMENTAL
Intervention: Exogenous melatonin (2.5 mg, orally) during the daytime (n = 6)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Suppression of endogenous nocturnal melatonin secretion by atenolol (100 mg; n = 6)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Daytime melatonin administration
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Nocturnal melatonin suppression
Number of subjects: 12
Study: 6712031

Group type: EXPERIMENTAL
Intervention: High dose recombinant alpha-2 interferon (50 X 10(6) U/m2 body surface area, intravenously)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Low dose recombinant alpha-2 interferon (1 X 10(6) U/m2, subcutaneously)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both high and low doses of recombinant alpha-2 interferon
Number of subjects: 20
Study: 30226424

Group type: EXPERIMENTAL
Intervention: Pseudomonas syringae pv. actinidiae strains from China
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: Chinese strains of Pseudomonas syringae pv. actinidiae
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: Strain Jzhy2 from China
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: Strains from China
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: All strains including K3 isolated in 1997 from Jeju, Korea
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: K3 and biovar 1 strains (K3, Kw30, and Psa92)
Number of subjects: 269
Study: 29059451

Group type: EXPERIMENTAL
Intervention: Nicotine administration
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo administration
Number of subjects: 11
Study: 27173976

Group type: EXPERIMENTAL
Intervention: CF-on (contact force data available)
Number of subjects: 117

Group type: COMPARATOR
Intervention: CF-off (contact force data not available)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: CF-on
Number of subjects: 117

Group type: COMPARATOR
Intervention: CF-off
Number of subjects: 117
Study: 24476536

Group type: EXPERIMENTAL
Intervention: Intrauterine injection of 500 IU of human chorionic gonadotropin (hCG) before embryo transfer
Number of subjects: 210

Group type: COMPARATOR
Intervention: Control group (no hCG injection)
Number of subjects: 210
Study: 23176133

Group type: EXPERIMENTAL
Intervention: Best practice usual care supplemented with an individualised exercise programme of strengthening and stretching exercises
Number of subjects: 480

Group type: COMPARATOR
Intervention: Best practice usual care (joint protection advice, general exercise advice, functional splinting and assistive devices)
Number of subjects: 480
Study: 20665209

Group type: EXPERIMENTAL
Intervention: Oxycodone (5, 10, and 20 mg/10 ml)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Hydrocodone (5, 10, and 20 mg/10 ml)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Morphine (5, 10, and 20 mg/10 ml)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 9
Study: 17968156

Group type: EXPERIMENTAL
Intervention: Preoperative short-term radiotherapy (5 x 5 Gy)
Number of subjects: 1861

Group type: COMPARATOR
Intervention: TME alone (no radiotherapy)
Number of subjects: 1861
Study: 15610250

Group type: EXPERIMENTAL
Intervention: ACE inhibitors
Number of subjects: 1860

Group type: COMPARATOR
Intervention: Control
Number of subjects: 1860
Study: 11939936

Group type: EXPERIMENTAL
Intervention: Entacapone (200 mg)
Number of subjects: 301

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 301
Study: 9704792

Group type: EXPERIMENTAL
Intervention: Systemic lupus erythematosus (SLE)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Antiphospholipid antibody
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Chronic villitis
Number of subjects: 33
Study: 8580691

Group type: EXPERIMENTAL
Intervention: More concentrated PAP (10 ml = 15 grams of Astragalus)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Less concentrated PAP (10 ml = 5 grams of Astragalus)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Both groups (after treatment)
Number of subjects: 115
Study: 31192359

Group type: EXPERIMENTAL
Intervention: Supervised machine learning approach using PBP sequences and MIC values to predict antimicrobial susceptibility to beta-lactam antibiotics.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Use of fragments from pbp2x (750 bp) and pbp2b (750 bp) for prediction.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Association analysis between resistance phenotypes and serotypes/sequence types of S. pneumoniae.
Number of subjects: 0
Study: 28251282

Group type: EXPERIMENTAL
Intervention: S-1 alternate-day treatment (twice daily on alternate days from days 1 through 42 of a 42-day cycle)
Number of subjects: 190

Group type: COMPARATOR
Intervention: S-1 daily treatment (twice daily on days 1 through 28 of a 42-day cycle)
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: S-1 alternate-day treatment
Number of subjects: 190

Group type: COMPARATOR
Intervention: S-1 daily treatment
Number of subjects: 190
Study: 25381486

Group type: EXPERIMENTAL
Intervention: Chlorhexidine gluconate
Number of subjects: 351

Group type: COMPARATOR
Intervention: Povidone iodine
Number of subjects: 351
Study: 24340926

Group type: EXPERIMENTAL
Intervention: Rheumatoid arthritis patients with normal BMI
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Rheumatoid arthritis patients with obesity
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group (healthy individuals)
Number of subjects: 41
Study: 20943824

Group type: COMPARATOR
Intervention: Self-administered questionnaire (SAQ)
Number of subjects: 1495

Group type: COMPARATOR
Intervention: Audio‐SAQ
Number of subjects: 1495

Group type: COMPARATOR
Intervention: Informal confidential voting interview (ICVI)
Number of subjects: 1495

Group type: COMPARATOR
Intervention: Audio computer‐assisted survey instrument (ACASI)
Number of subjects: 1495
Study: 18710817

Group type: EXPERIMENTAL
Intervention: Nerve growth factor (NGF) injection in trapezius muscle
Number of subjects: 10

Group type: COMPARATOR
Intervention: Isotonic saline injection in trapezius muscle (control)
Number of subjects: 10
Study: 16752180

Group type: EXPERIMENTAL
Intervention: [U‐(13)C]glucose and [3‐(14)C]lactate infusion during a 24‐h fast
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control group (age‐ and BMI‐matched)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Diabetic subjects
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Melatonin secretion
Number of subjects: 13
Study: 15177970

Group type: EXPERIMENTAL
Intervention: One 600‐mg tablet (group 1A, 13 patients sampled < 2 hours after administration)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: One 600‐mg tablet (group 1B, 9 patients sampled > 2 hours after administration)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Two doses of 600 mg given 12 hours apart (group 2, 7 patients)
Number of subjects: 29
Study: 11387491

Group type: EXPERIMENTAL
Intervention: Focal transcranial magnetic stimulation (TMS) over motor and premotor cortices
Number of subjects: 41
Study: 9408786

Group type: EXPERIMENTAL
Intervention: CATCH intervention programs (school food service, physical education, classroom curricula, home programs)
Number of subjects: 0
Study: 7678976

Group type: EXPERIMENTAL
Intervention: Epirubicin/5-Fluorouracil
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Cisplatinum
Number of subjects: 16
Study: 3112262

Group type: EXPERIMENTAL
Intervention: Intravenous midazolam (0.1 mg/kg)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 28497206

Group type: EXPERIMENTAL
Intervention: Online group (taught by videos)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Classroom group (traditional lecture with hands-on training)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (not taught at all)
Number of subjects: 54
Study: 27391406

Group type: EXPERIMENTAL
Intervention: Psychosocial intervention (counselling sessions led by a social worker)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 74
Study: 24225450

Group type: EXPERIMENTAL
Intervention: 40 mg daidzein (DAI40)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: 80 mg daidzein (DAI80)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 210
Study: 22101910

Group type: EXPERIMENTAL
Intervention: Rosiglitazone (4 mg/d)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Diet alone (Control)
Number of subjects: 55
Study: 20937093

Group type: EXPERIMENTAL
Intervention: Nebulized heparin (25,000 U) administered 4 or 6 hourly depending on patient height
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo (normal saline) administered 4 or 6 hourly depending on patient height
Number of subjects: 50
Study: 18763689

Group type: EXPERIMENTAL
Intervention: Sonicare Elite (Elite)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Oral‐B P40 manual toothbrush (MTB)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Both toothbrushes
Number of subjects: 180
Study: 15983958

Group type: EXPERIMENTAL
Intervention: Cinacalcet (30 to 180 mg once daily)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 14763035

Group type: EXPERIMENTAL
Intervention: Valsartan (ARB)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 10582841

Group type: EXPERIMENTAL
Intervention: Continuous Performance Test (CPT)
Number of subjects: 341
Study: 8609293

Group type: EXPERIMENTAL
Intervention: Target fixed at 753 Hz, distractor frequencies: 353, 553, 653, 703, 803, 853, 953, 1153 Hz; interaural delays varied from -90 to +90 microseconds in 20-microsecond steps; 100 trials per block.
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Distractor fixed at 753 Hz, target frequencies: 353, 553, 653, 703, 803, 953, 1153 Hz; interaural delays varied from -90 to +90 microseconds in 20-microsecond steps; 100 trials per block.
Number of subjects: 8
Study: 1911483

Group type: EXPERIMENTAL
Intervention: Absorbable subcuticular sutures
Number of subjects: 304

Group type: COMPARATOR
Intervention: Non-absorbable interrupted sutures
Number of subjects: 304
Study: 31478731

Group type: EXPERIMENTAL
Intervention: S. aureus positive isolates
Number of subjects: 311

Group type: EXPERIMENTAL
Intervention: Methicillin-resistant strains
Number of subjects: 311

Group type: EXPERIMENTAL
Intervention: Multi-drug resistance
Number of subjects: 311

Group type: COMPARATOR
Intervention: Risk factors evaluation
Number of subjects: 311
Study: 30305263

Group type: EXPERIMENTAL
Intervention: Cool Runnings app-based intervention
Number of subjects: 498

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 498
Study: 26115954

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) for depression, 8 weeks
Number of subjects: 53

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 53
Study: 24239594

Group type: EXPERIMENTAL
Intervention: Rivastigmine 3mg
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Rivastigmine 6mg
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study: 22916864

Group type: EXPERIMENTAL
Intervention: Titanium-polyethylene (TI) implant
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Pyrocarbon (PY) implant
Number of subjects: 43

Group type: COMPARATOR
Intervention: Silicone (SI) spacer
Number of subjects: 43
Study: 20581660

Group type: EXPERIMENTAL
Intervention: Dexamethasone (HD-DXM) at single daily doses of 40 mg for 4 consecutive days
Number of subjects: 36

Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 36
Study: 17295794

Group type: EXPERIMENTAL
Intervention: Probiotic supplementation (daily for the first 6 months of life)
Number of subjects: 231

Group type: COMPARATOR
Intervention: Placebo (daily for the first 6 months of life)
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: Both Probiotic and Placebo groups (for those who developed atopic dermatitis)
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: Probiotic group (specifically)
Number of subjects: 231
Study: 15919837

Group type: EXPERIMENTAL
Intervention: Bioelectrical impedance analysis (BIA)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: BodPod (Siri)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: BodPod (Brozek)
Number of subjects: 56

Group type: COMPARATOR
Intervention: DXA
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Correlation coefficients for detecting changes in body composition
Number of subjects: 56
Study: 12602413

Group type: EXPERIMENTAL
Intervention: NIV plus LTOT
Number of subjects: 0

Group type: COMPARATOR
Intervention: LTOT
Number of subjects: 0
Study: 10714795

Group type: EXPERIMENTAL
Intervention: Rapid same day multiplex PCR assay for detection of the staphylococcal mecA (mean delay of response: 6 h)
Number of subjects: 145

Group type: COMPARATOR
Intervention: Traditional overnight techniques (21 h)
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Rapid same day multiplex PCR assay for detection of the staphylococcal mecA
Number of subjects: 145

Group type: COMPARATOR
Intervention: Traditional overnight techniques
Number of subjects: 145
Study: 8746877

Group type: EXPERIMENTAL
Intervention: Levonorgestrel-IUD 5 micrograms/24 h
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Levonorgestrel-IUD 10 micrograms/24 h
Number of subjects: 51
Study: 2036815

Group type: EXPERIMENTAL
Intervention: Aerosol therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Humidity therapy
Number of subjects: 0
Study: 7094200

Group type: EXPERIMENTAL
Intervention: Chemotherapy (with or without radiotherapy) plus MER/BCG (RCM)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Chemotherapy either alone or in combination with radiotherapy (RC)
Number of subjects: 73
Study: 28772092

Group type: EXPERIMENTAL
Intervention: Specialty palliative care in addition to standard oncology care
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard oncology care alone
Number of subjects: 30
Study: 26947543

Group type: COMPARATOR
Intervention: Intravenous TXA (IVTXA)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Topical TXA (TTXA)
Number of subjects: 70
Study: 25552287

Group type: EXPERIMENTAL
Intervention: RTF plus PRF
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: PRF
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control
Number of subjects: 36
Study: 23820670

Group type: EXPERIMENTAL
Intervention: Peer support
Number of subjects: 106

Group type: COMPARATOR
Intervention: Psychoeducation
Number of subjects: 106

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 106
Study: 20872194

Group type: EXPERIMENTAL
Intervention: Tiotropium and salmeterol (experimental group, n = 10)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (n = 10)
Number of subjects: 20
Study: 18215253

Group type: EXPERIMENTAL
Intervention: Preoperative melatonin application
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 40
Study: 16617223

Group type: EXPERIMENTAL
Intervention: Exercise training (aerobic exercise and muscle strengthening, 24 sessions over 2 months)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Exercise training
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (2-month control period)
Number of subjects: 30
Study: 14711141

Group type: EXPERIMENTAL
Intervention: PDT using ALA plus blue light
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: PDT using ALA plus laser light
Number of subjects: 36

Group type: COMPARATOR
Intervention: Topical 5‐FU
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: PDT treatments (both types)
Number of subjects: 36
Study: 11281438

Group type: EXPERIMENTAL
Intervention: Amoxycillin 500 mg tid + Omeprazole 20 mg bd
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Amoxycillin 750 mg tds + Omeprazole 20 mg bd
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Clarithromycin 500 mg tid + Omeprazole 20 mg bd
Number of subjects: 148
Study: 9426077

Group type: EXPERIMENTAL
Intervention: Mannitol inhalation (267 mg and 400 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Mannitol inhalation
Number of subjects: 12
Study: 8229541

Group type: COMPARATOR
Intervention: 0% MCT oil
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: 50% MCT oil
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: 17% MCT oil
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: 34% MCT oil
Number of subjects: 64
Study: 3941767

Group type: EXPERIMENTAL
Intervention: Primidone (50 to 1,000 mg/d)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Primidone (250 mg single oral dose)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Primidone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Phenobarbital (substituted for primidone)
Number of subjects: 0
Study: 29280940

Group type: EXPERIMENTAL
Intervention: Bevacizumab
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Aflibercept
Number of subjects: 72

Group type: COMPARATOR
Intervention: Ranibizumab
Number of subjects: 72
Study: 26816389

Group type: EXPERIMENTAL
Intervention: Combo (tracksuit pants with integrated heating elements and 5-min dryland-based exercise routine)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (conventional tracksuit and seated)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Combo
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control
Number of subjects: 10
Study: 23812661

Group type: EXPERIMENTAL
Intervention: LEAP
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: TEACCH
Number of subjects: 198

Group type: COMPARATOR
Intervention: Control (non-model-specific practices)
Number of subjects: 198
Study: 23887656

Group type: EXPERIMENTAL
Intervention: Aliskiren add-on therapy
Number of subjects: 36

Group type: COMPARATOR
Intervention: Benazepril add-on therapy
Number of subjects: 36
Study: 19878195

Group type: EXPERIMENTAL
Intervention: Mannitol
Number of subjects: 55

Group type: COMPARATOR
Intervention: Hypertonic saline (4.5%)
Number of subjects: 55
Study: 17551539

Group type: EXPERIMENTAL
Intervention: Nicotine (2 mg via polacrilex gums)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 24
Study: 17283933

Group type: EXPERIMENTAL
Intervention: Convex vertices
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Concave vertices
Number of subjects: 0

Group type: COMPARATOR
Intervention: Silhouettes
Number of subjects: 0
Study: 12543749

Group type: EXPERIMENTAL
Intervention: Optic disc area measurement
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Neuroretinal rim area measurement
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Horizontal cup/disc diameter ratio
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Alpha zone of parapapillary atrophy
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Beta zone of parapapillary atrophy
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Retinal arterioles and venules visibility
Number of subjects: 70

Group type: COMPARATOR
Intervention: Comparison with white people
Number of subjects: 70
Study: 9930157

Group type: EXPERIMENTAL
Intervention: High-pass resolution perimetry
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Conventional perimetry
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 113

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 113
Study: 8881668

Group type: EXPERIMENTAL
Intervention: Higher-dose regimen based on minimal phototoxic dose (MPD)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Lower dose regimen based on skin type
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Both regimens
Number of subjects: 33
Study: 1909584

Group type: EXPERIMENTAL
Intervention: misoprostol 400 micrograms nocte
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: ranitidine 150 mg nocte
Number of subjects: 61

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 61
Study: 4084931

Group type: EXPERIMENTAL
Intervention: Impedance cardiography during maximum exercise tests
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Impedance cardiography
Number of subjects: 20
Study: 30683150

Group type: EXPERIMENTAL
Intervention: Multi-component sensory intervention including assessment and correction of hearing or vision impairments (or both), home-based (maximum 10 visits over 18 weeks), therapist-delivered sensory support
Number of subjects: 354

Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 354
Study: 28876283

Group type: EXPERIMENTAL
Intervention: Internet-based HIV prevention intervention
Number of subjects: 199

Group type: COMPARATOR
Intervention: Participants with homelessness
Number of subjects: 199

Group type: COMPARATOR
Intervention: Participants with clinically significant depressive symptoms
Number of subjects: 199

Group type: COMPARATOR
Intervention: Participants who used methamphetamine or crack
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Participants who engaged in condomless insertive anal intercourse
Number of subjects: 199
Study: 27088635

Group type: EXPERIMENTAL
Intervention: Flavanol-rich chocolate
Number of subjects: 32

Group type: COMPARATOR
Intervention: Flavanol-poor chocolate
Number of subjects: 32
Study: 25295737

Group type: EXPERIMENTAL
Intervention: Bevacizumab + taxane-based chemotherapy
Number of subjects: 365

Group type: EXPERIMENTAL
Intervention: Safety analysis of bevacizumab
Number of subjects: 365
Study: 22394693

Group type: EXPERIMENTAL
Intervention: Komm mit in das gesunde Boot ‐ Grundschule program
Number of subjects: 427

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 427
Study: 20880343

Group type: EXPERIMENTAL
Intervention: Insulin lispro mix 50/50 (LM50/50)
Number of subjects: 484

Group type: COMPARATOR
Intervention: Insulin glargine plus ≤3 mealtime lispro (G+L)
Number of subjects: 484

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 484
Study: 18035140

Group type: EXPERIMENTAL
Intervention: Insulin (0.025 U/kg/hr) on days 1 to 7 with 20% dextrose to maintain normoglycemia
Number of subjects: 16

Group type: COMPARATOR
Intervention: Standard neonatal care
Number of subjects: 16
Study: 16173851

Group type: EXPERIMENTAL
Intervention: Couple-focused group intervention (6 sessions)
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Couple-focused group intervention
Number of subjects: 238

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 238
Study: 12753317

Group type: EXPERIMENTAL
Intervention: Raloxifene hydrochloride, 60 mg/day
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 11421376

Group type: EXPERIMENTAL
Intervention: Albendazole 20 mg/kg with cimetidine 10 mg/kg twice daily
Number of subjects: 6

Group type: COMPARATOR
Intervention: Albendazole 5 mg/kg
Number of subjects: 6